1. Consider expenditure controls' impacts on equity. (June 2021) Authors: Frick, Kevin D; Kacker, Seema; Ballreich, Jeromie Journal: EClinicalMedicine Issue: Volume 36(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Constructing a model: economic evaluations in transfusion medicine, Part 3. Issue 9 (8th April 2013) Authors: Kacker, Seema; Frick, Kevin D.; Tobian, Aaron A.R. Journal: Transfusion Issue: Volume 53:Issue 9(2013) Page Start: 1885 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cost‐effectiveness of prospective red blood cell antigen matching to prevent alloimmunization among sickle cell patients. Issue 1 (21st May 2013) Authors: Kacker, Seema; Ness, Paul M.; Savage, William J.; Frick, Kevin D.; Shirey, R. Sue; King, Karen E.; Tobian, Aaron A.R. Journal: Transfusion Issue: Volume 54:Issue 1(2014) Page Start: 86 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Data and interpretation: economic evaluations in transfusion medicine, Part 4. Issue 10 (8th April 2013) Authors: Kacker, Seema; Frick, Kevin D.; Tobian, Aaron A.R. Journal: Transfusion Issue: Volume 53:Issue 10(2013) Page Start: 2130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Economic evaluation of a hypothetical screening assay for alloimmunization risk among transfused patients with sickle cell disease. Issue 8 (27th February 2014) Authors: Kacker, Seema; Ness, Paul M.; Savage, William J.; Frick, Kevin D.; Shirey, R. Sue; King, Karen E.; Tobian, Aaron A.R. Journal: Transfusion Issue: Volume 54:Issue 8(2014) Page Start: 2034 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Establishing a framework: economic evaluations in transfusion medicine, Part 2. Issue 8 (8th April 2013) Authors: Kacker, Seema; Frick, Kevin D.; Tobian, Aaron A.R. Journal: Transfusion Issue: Volume 53:Issue 8(2013) Page Start: 1634 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Financial analysis of large‐volume delayed sampling to reduce bacterial contamination of platelets. Issue 5 (10th April 2020) Authors: Kacker, Seema; Katz, Louis M.; Ness, Paul M.; Bloch, Evan M.; Goel, Ruchika; Gehrie, Eric A.; Lokhandwala, Parvez M.; Tobian, Aaron A.R. Journal: Transfusion Issue: Volume 60:Issue 5(2020) Page Start: 997 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Financial impact of alternative approaches to reduce bacterial contamination of platelet transfusions. Issue 4 (8th January 2019) Authors: Kacker, Seema; Bloch, Evan M.; Ness, Paul M.; Gehrie, Eric A.; Marshall, Christi E.; Lokhandwala, Parvez M.; Tobian, Aaron A.R. Journal: Transfusion Issue: Volume 59:Issue 4(2019) Page Start: 1291 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Financial implications of RHD genotyping of pregnant women with a serologic weak D phenotype. Issue 9 (21st March 2015) Authors: Kacker, Seema; Vassallo, Ralph; Keller, Margaret A.; Westhoff, Connie M.; Frick, Kevin D.; Sandler, S. Gerald; Tobian, Aaron A.R. Journal: Transfusion Issue: Volume 55:Issue 9(2015) Page Start: 2095 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Medical and economic implications of strategies to prevent alloimmunization in sickle cell disease. Issue 9 (26th June 2017) Authors: Gehrie, Eric A.; Ness, Paul M.; Bloch, Evan M.; Kacker, Seema; Tobian, Aaron A. R. Journal: Transfusion Issue: Volume 57:Issue 9(2017) Page Start: 2267 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗